• Medical Research Institute
  • Tokyo Medical and Dental University
  • Access



  • K. Okita, H. Kiyonari, I. Nobuhisa, N. Kimura, S. Aizawa, and T. Taga. Targeted disruption of the mouse ELYS gene results in embryonic death at peri-implantation development. Genes Cells , 9:1083-1091, 2004.
  • M. Yanagisawa, K. Nakamura, and T. Taga. Roles of lipid rafts in integrin-dependent adhesion and gp130 signaling pathway in mouse embryonic neural precursor cells. Genes Cells , 9:801-809, 2004.
  • M. Namihira, K. Nakashima, and T. Taga. Development stage dependent regulation of DNA methylation and chromatin modification in a immature astrocyte specific gene promoter. FEBS Lett . , 572:184-188, 2004.
  • T. Setoguchi, K. Nakashima, T. Takizawa, M. Yanagisawa, W. Ochiai, M. Okabe, K. Yone, S. Komiya, and T. Taga. Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor. Exp. Neurol. , 189:33-44, 2004.
  • T. Setoguchi, T. Taga, and T. Kondo. Cancer stem cells persist in many cancer cell lines. Cell Cycle 3:414-415, 2004.
  • T. Kondo, T. Setoguchi, and T. Taga. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA , 101:781-786, 2004.
  • I. Nobuhisa, R. Kato, H. Inoue, M. Takizawa, K. Okita, A. Yoshimura, and T. Taga. Spred-2 suppresses aorta-gonad-mesonephros hematopoiesis by inhibiting MAP kinase activation. J. Exp. Med. , 199:737-742, 2004.
  • S. Fukuda, T. Kondo, H. Takebayashi, and T. Taga. Negative regulatory effect of an oligodendrocytic bHLH factor OLIG2 on the astrocytic differentiation pathway. Cell Death Differ. , 11:196-202. 2004.
  • H. Inoue, I. Nobuhisa, K. Okita, M. Takizawa, Marie-Josephe Pebusque, and T. Taga. Negative regulation of hematopoiesis by the fused in myeloproliferative disorders gene product. Biochem. Biophys. Res. Commun. , 313:125-128, 2004.